TrialBritish journal of cancer2026

Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).

Manfred P Lutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.